In utero Exposure to beta-2-Adrenergic Receptor Agonist Drugs and Risk for Autism Spectrum Disorders

Medicine & Life Sciences

• Adrenergic Agonists 37%
• Adrenergic beta-2 Receptor Agonists 100%
• Adrenergic Receptors 18%
• Asthma 7%
• Autism Spectrum Disorder 61%
• Case-Control Studies 7%
• Child 4%
• Confidence Intervals 35%
• Denmark 10%
• First Pregnancy Trimester 10%
• Health 4%
• Logistic Models 12%
• Mothers 6%
• Odds Ratio 37%
• Parturition 6%
• Pharmaceutical Preparations 24%
• Pregnancy 29%
• Pregnancy Trimesters 13%
• Pregnant Women 7%
• Registries 7%
• Second Pregnancy Trimester 10%
• Third Pregnancy Trimester 10%